Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zipp

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Neurology|June 1, 1995
The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosisR Hohlfeld, E Meinl, F Weber, et al.
Annals of Neurology|November 1, 1995
Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cellsF Zipp, F Weber, S Huber, et al.
Der Nervenarzt|June 10, 2011
[Risk stratification of progressive multifocal leukoencephalopathy under natalizumab: recommendations for JC virus serology]C Warnke, O Adams, H P Hartung, et al.
Neurology|May 9, 2007
Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathyB Tackenberg, J D Lünemann, A Steinbrecher, et al.
Inorganic Chemistry|April 12, 2014
The synthesis of a corrole analogue of aquacobalamin (vitamin B12a) and its ligand substitution reactionsCaitlin F Zipp, Joseph P Michael, Manuel A Fernandes, et al.
European Radiology|March 25, 2009
MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal studyJ Bellmann-Strobl, H Stiepani, J Wuerfel, et al.
Brain : a Journal of Neurology|August 26, 1998
Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosisF Zipp, M Kerschensteiner, K Dornmair, et al.
Journal of Neurology|February 19, 2014
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosisT L Vollmer, P S Sorensen, K Selmaj, et al.
Journal of Neuroimmunology|November 27, 2009
Dysregulated Epstein-Barr virus infection in patients with CIDPJ D Lünemann, B Tackenberg, A Stein, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2011
Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional studyC Veauthier, H Radbruch, G Gaede, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Neurology|June 1, 1995
The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosisR Hohlfeld, E Meinl, F Weber, et al.
Annals of Neurology|November 1, 1995
Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cellsF Zipp, F Weber, S Huber, et al.
Der Nervenarzt|June 10, 2011
[Risk stratification of progressive multifocal leukoencephalopathy under natalizumab: recommendations for JC virus serology]C Warnke, O Adams, H P Hartung, et al.
Neurology|May 9, 2007
Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathyB Tackenberg, J D Lünemann, A Steinbrecher, et al.
Inorganic Chemistry|April 12, 2014
The synthesis of a corrole analogue of aquacobalamin (vitamin B12a) and its ligand substitution reactionsCaitlin F Zipp, Joseph P Michael, Manuel A Fernandes, et al.
European Radiology|March 25, 2009
MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal studyJ Bellmann-Strobl, H Stiepani, J Wuerfel, et al.
Brain : a Journal of Neurology|August 26, 1998
Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosisF Zipp, M Kerschensteiner, K Dornmair, et al.
Journal of Neurology|February 19, 2014
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosisT L Vollmer, P S Sorensen, K Selmaj, et al.
Journal of Neuroimmunology|November 27, 2009
Dysregulated Epstein-Barr virus infection in patients with CIDPJ D Lünemann, B Tackenberg, A Stein, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2011
Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional studyC Veauthier, H Radbruch, G Gaede, et al.
Pageof 9